Recurrence Rate of Melanoma in Situ when Treated with Serial Disk Staged Excision: A Case Series
- PMID: 28936478
- PMCID: PMC5603294
- DOI: 10.13188/2373-1044.1000037
Recurrence Rate of Melanoma in Situ when Treated with Serial Disk Staged Excision: A Case Series
Abstract
Background: Cutaneous melanoma is one of the fastest rising cancer diagnoses in recent years. Melanoma in situ (MIS) constitutes a large proportion of all diagnosed melanomas. While surgical excision is considered the standard of therapy, the literature is not clear on which surgical technique minimizes local recurrence. A common technique is serial staged excision (SSE), in which a series of mapped excisions are made according to histopathological examination of tissue. Previously published recurrence rates for SSE ranges from 0-12%, over a range of 4.7-97 months of mean follow-up.
Objective: To investigate the recurrence rate of MIS when excised using a serial disk staged excision technique with tissue marked at 12 O'clock for mapping, rush permanent processing and histologic examination, 3-suture tagging for subsequent stages, and "breadloafing" microscopic analysis. Additionally, to determine the relationship between initial lesion size and subsequent stages of excision required for clearance, and final surgical margin.
Methods: Single-institution retrospective chart review of 29 biopsy confirmed MIS lesions treated with our variant of SSE. Statistical analysis via independent t-tests.
Results: No recurrences were observed with mean follow-up of 31.5 months (SD 13.9), over range of 12-58 months. Mean surgical margin of 13.1 mm (SD 5.9). A trend towards larger surgical margin was seen with increasing pre-operative lesion size.
Conclusion: This method of SSE for treatment of MIS is comparable in efficacy to other SSE techniques, and may offer physicians a relatively simple, efficacious, and accessible alternative to wide local excision and Mohs micrographic surgery.
Keywords: Dermatology; Excision; Lentigo maligna (LM); Malignant melanoma (MM); Melanoma in situ (MIS); Skin; Staged excision.
Figures
Similar articles
-
No Recurrence in Primary Invasive Stage 1a and 1b Melanoma and Melanoma in Situ Treated With Serial Disk Staged Excision.Dermatol Surg. 2022 Mar 1;48(3):276-282. doi: 10.1097/DSS.0000000000003357. Dermatol Surg. 2022. PMID: 34935746
-
Surgical management of melanoma-in-situ using a staged marginal and central excision technique.Ann Surg Oncol. 2009 Jun;16(6):1526-36. doi: 10.1245/s10434-008-0239-x. Epub 2008 Dec 3. Ann Surg Oncol. 2009. PMID: 19050971
-
Treatment options in melanoma in situ: topical and radiation therapy, excision and Mohs surgery.Int J Dermatol. 2010 May;49(5):482-91. doi: 10.1111/j.1365-4632.2010.04423.x. Int J Dermatol. 2010. PMID: 20534080 Review.
-
An assessment of histological margins and recurrence of melanoma in situ.Plast Reconstr Surg Glob Open. 2015 Mar 6;3(2):e301. doi: 10.1097/GOX.0000000000000272. eCollection 2015 Feb. Plast Reconstr Surg Glob Open. 2015. PMID: 25750840 Free PMC article.
-
Staged margin control techniques for surgical excision of lentigo maligna.G Ital Dermatol Venereol. 2009 Jun;144(3):259-70. G Ital Dermatol Venereol. 2009. PMID: 19528907 Review.
Cited by
-
Histological Peripheral Margins and Recurrence of Melanoma In Situ Treated with Wide Local Excision.J Skin Cancer. 2020 Oct 29;2020:8813050. doi: 10.1155/2020/8813050. eCollection 2020. J Skin Cancer. 2020. PMID: 33178463 Free PMC article.
-
Staged melanoma excision requires larger margins for tumor clearance and results in low rates of recurrence.Arch Dermatol Res. 2023 May;315(4):933-942. doi: 10.1007/s00403-022-02426-z. Epub 2022 Nov 22. Arch Dermatol Res. 2023. PMID: 36416976 Review.
-
Melanoma In Situ: A Critical Review and Re-Evaluation of Current Excision Margin Recommendations.Adv Ther. 2021 Jul;38(7):3506-3530. doi: 10.1007/s12325-021-01783-x. Epub 2021 May 28. Adv Ther. 2021. PMID: 34047915 Free PMC article. Review.
-
Evaluation of skin cancer screening in Germany - a Microsimulation.J Dtsch Dermatol Ges. 2025 Jan;23(1):19-27. doi: 10.1111/ddg.15539. Epub 2024 Nov 9. J Dtsch Dermatol Ges. 2025. PMID: 39520317 Free PMC article.
-
Ten-year Follow-up Study of Grenz Ray Treatment for Lentigo Maligna and Early Lentigo Maligna Melanoma.Acta Derm Venereol. 2020 Oct 6;100(17):adv00282. doi: 10.2340/00015555-3631. Acta Derm Venereol. 2020. PMID: 32926174 Free PMC article.
References
-
- Lens MB, Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol. 2004;150:179–185. - PubMed
-
- Weinstock MA, Sober AJ. The risk of progression of lentigo maligna to lentigo maligna melanoma. Br J Dermatol. 1987;116:303–310. - PubMed
-
- McKenna JK, Florell SR, Goldman GD, Bowen GM. Lentigo maligna/lentigo maligna melanoma: current state of diagnosis and treatment. Dermatol Surg. 2006;32:493–504. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources